Activation of the Nrf2 pathway, but decreased gamma-glutamylcysteine synthetase heavy subunit chain levels and caspase-3-dependent apoptosis during exposure of primary mouse hepatocytes to diphenylarsinic acid.

[1]  D. Sumi,et al.  Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. , 2007, Annual review of pharmacology and toxicology.

[2]  Kayoko Kita,et al.  Glutathione plays a role in regulating the formation of toxic reactive intermediates from diphenylarsinic acid. , 2006, Toxicology.

[3]  T. Ishii,et al.  Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes , 2006, FEBS letters.

[4]  H. Aposhian,et al.  Arsenic toxicology: five questions. , 2006, Chemical research in toxicology.

[5]  Makoto Kobayashi,et al.  Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. , 2005, Antioxidants & redox signaling.

[6]  F. Otsuka,et al.  Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan , 2004, Annals of neurology.

[7]  T. Kaise,et al.  In vitro cytotoxic and genotoxic effects of diphenylarsinic acid, a degradation product of chemical warfare agents. , 2004, Toxicology and applied pharmacology.

[8]  S. Hirano,et al.  The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. , 2004, Toxicology and applied pharmacology.

[9]  S. Hirano,et al.  Accumulation and toxicity of monophenyl arsenicals in rat endothelial cells , 2004, Archives of Toxicology.

[10]  Wei Qu,et al.  Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. , 2003, Experimental cell research.

[11]  T. Kavanagh,et al.  TGFβ1‐induced suppression of glutathione antioxidant defenses in hepatocytes: caspase‐dependent posttranslational and caspase‐independent transcriptional regulatory mechanisms , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  K. Itoh,et al.  Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. , 2003, Biochemical and biophysical research communications.

[13]  S. Hirano,et al.  Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells , 2003, Archives of Toxicology.

[14]  T. Inaoka,et al.  Skin manifestations of arsenicosis in two villages in Bangladesh , 2002, International Journal of Dermatology.

[15]  D. Nordstrom.  Worldwide Occurrences of Arsenic in Ground Water , 2002, Science.

[16]  K. Itoh,et al.  A Sulforaphane Analogue That Potently Activates the Nrf2-dependent Detoxification Pathway* , 2002, The Journal of Biological Chemistry.

[17]  R. S. Magee,et al.  Critical evaluation of proven chemical weapon destruction technologies (IUPAC Technical Report) , 2002 .

[18]  Jie Liu,et al.  Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. , 2001, Molecular pharmacology.

[19]  M. Freeman,et al.  Multi‐faceted regulation of γ‐glutamylcysteine synthetase , 2000 .

[20]  Wild Ac,et al.  Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. , 1999 .

[21]  O. Griffith,et al.  Biologic and pharmacologic regulation of mammalian glutathione synthesis. , 1999, Free radical biology & medicine.

[22]  Y. Akao,et al.  Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro , 1999, FEBS letters.

[23]  Shelly C. Lu.  Regulation of hepatic glutathione synthesis: current concepts and controversies , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  M. W. Anders,et al.  Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis. , 1998, The Biochemical journal.

[25]  Jen-kun Lin,et al.  Involvement of reactive oxygen species and caspase 3 activation in arsenite‐induced apoptosis , 1998, Journal of cellular physiology.

[26]  R. Flavell,et al.  Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. , 1997, Cancer research.

[27]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[28]  E. Alnemri,et al.  Resistance of actin to cleavage during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Rossman,et al.  Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells. , 1996, Toxicology and applied pharmacology.

[30]  M. Lai,et al.  Increased prevalence of hypertension and long-term arsenic exposure. , 1995, Hypertension.

[31]  A. Smith,et al.  Vascular effects of chronic arsenic exposure: a review. , 1994, Epidemiologic reviews.

[32]  Te-Chang Lee,et al.  Glutathione S-Transferase π Facilitates the Excretion of Arsenic from Arsenic-Resistant Chinese Hamster Ovary Cells , 1993 .

[33]  T. Lee,et al.  Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line. , 1992, The Biochemical journal.

[34]  W. Tseng,et al.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. , 1968, Journal of the National Cancer Institute.